Born to Age: When Adult Congenital Heart Disease Converges With Geroscience

Philip Moons1,2,3, Ariane Marelli4

  • 1KU Leuven Department of Public Health and Primary Care, KU Leuven, Leuven, Belgium.

JACC. Advances
|June 28, 2024
PubMed

Insights

Congenital heart disease (CHD) patients are living longer, necessitating a deeper understanding of aging. This review explores demographic shifts, complications, and aging concepts to improve care for this growing population.

Area of Science:

  • Cardiology
  • Gerontology
  • Internal Medicine

Background:

  • Medical advancements have shifted the congenital heart disease (CHD) population towards older age groups.
  • Understanding the aging process is crucial for managing the evolving needs of CHD patients.
  • Systemic complications in younger CHD patients require consideration in the context of aging.

Purpose of the Study:

  • To analyze demographic changes in the CHD population.
  • To describe systemic complications in young CHD patients.
  • To explore aging concepts applicable to CHD and the role of inflammation.

Main Methods:

  • Review of demographic data in CHD.
  • Description of systemic complications in young CHD patients.
  • Discussion of general aging principles and inflammation's impact.

Main Results:

  • The CHD population is aging due to improved medical interventions.
  • Aging in CHD may present unique systemic complications.
  • Inflammation is a key factor potentially influencing aging in CHD.

Conclusions:

  • A comprehensive understanding of aging is essential for the future management of CHD.
  • Bridging knowledge between geroscientists and CHD experts is vital.
  • Further research into aging's impact on CHD function is warranted.

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
168
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
916
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
627
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.8K
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.2K